Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial
节拍式口服长春瑞滨、环磷酰胺和卡培他滨与每周静脉注射紫杉醇治疗雌激素受体阳性、ERBB2阴性转移性乳腺癌患者的疗效:METEORA-II II期随机临床试验的最终结果
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2023.2150
Munzone, Elisabetta; Regan, Meredith M; Cinieri, Saverio; Montagna, Emilia; Orlando, Laura; Shi, Ruichao; Campadelli, Enrico; Gianni, Lorenzo; Palleschi, Michela; Petrelli, Fausto; Bengala, Carmelo; Generali, Daniele; Collovà, Elena; Puglisi, Fabio; Cretella, Elisabetta; Zamagni, Claudio; Chini, Claudio; Ruepp, Barbara; Loi, Sherene; Colleoni, Marco
肿瘤
肿瘤免疫
ERBB2
信号转导
乳腺癌
MET
免疫/内分泌